Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Aras Azadian
Recent news which mentions Aras Azadian
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
November 15, 2024
Tickers
AVCNF
NEWS
Tags
Cannabis
Market News
AVCNF
From
Benzinga
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
August 27, 2024
Tickers
AVCNF
NEWS
Tags
Psychedelics
Benzinga
Government
From
Benzinga
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
May 14, 2024
Tickers
AVCN
AVCNF
NEWS
Tags
Cannabis
Market News
TSX:AVCN
From
Benzinga
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
April 02, 2024
Tickers
AVCN
AVCNF
CCC
NEWS
Tags
Aras Azadian
AVCNF
TSX:AVCN
From
Benzinga
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
February 14, 2024
Tickers
AVCNF
CLVR
CLVRW
KHRNF
Tags
Colombia Cannabis Legalization
Benzinga
Clever Leaves Holdings Inc/
From
Benzinga
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
February 05, 2024
Tickers
AVCN
AVCNF
CBD
NEWS
Tags
Aras Azadian
AVCNF
TSX:AVCN
From
Benzinga
Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform
November 14, 2023
Tickers
AVCNF
Tags
Phil Cardella
Small Cap
milestone earnings
From
Benzinga
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
August 15, 2023
Tickers
AVCNF
Tags
AVCNF
Aras Azadian
Cannabis
From
Benzinga
This Cannabis Company Just Launched Medical Marijuana Care Platform And Finalized Important Acquisition
August 01, 2023
Tickers
AVCNF
Tags
News
premium
Penny Stocks
From
Benzinga
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
July 28, 2023
Tickers
AVCNF
Tags
premium
Penny Stocks
Benzinga
From
Benzinga
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
June 26, 2023
Tickers
AVCNF
MEDIF
Tags
premium
Benzinga
Penny Stocks
From
Benzinga
Avicanna And Northern Green Canada Execute Master Service Agreement To Operationalize MyMedi.ca
May 04, 2023
Tickers
AVCNF
Tags
Benzinga
AVCNF
Shoppers Drug Mart
From
Benzinga
Avicanna FY22 Revenue Grows 24%, Here Is What You Need To Know
April 03, 2023
Tickers
AVCNF
Tags
News
premium
Penny Stocks
From
Benzinga
Avicanna Stock Jumps On Partnership With Shoppers Drug Mart
March 28, 2023
Tickers
AVCNF
Tags
Benzinga
News
Jeff Leger
From
Benzinga
Avicanna Expands Its Pact With Al Harrington's Viola Brands To The UK
February 07, 2023
Tickers
AVCNF
Tags
Markets
Market News
Cannabis
From
Benzinga
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
August 18, 2022
Tickers
AVCNF
CCC
CLVR
CLVRW
Tags
Luis Merchan
Avicanna Inc/
AVCNF
From
Benzinga
Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference
August 15, 2022
Tickers
AMZN
AVCNF
CCC
WMT
Tags
WMT
CCC
Latin America
From
Benzinga
Avicanna, Ei. Ventures Partner To Develop And Launch Functional Fungi-Based Products
July 20, 2022
Tickers
AVCNF
Tags
Benzinga
Psychedelics
Market News
From
Benzinga
EXCLUSIVE: How Avicanna Is Advancing Plant-Derived, Cannabinoid-Based Products
April 21, 2022
Tickers
AVCNF
CCC
JNJ
NBA
Tags
Benzinga Cannabis Capital Conference
CCC22
Penny Stocks
From
Benzinga
Avicanna's Cannabinoid Drugs To Reach Brazil Via Its First 'Big Pharma' Deal
April 13, 2022
Tickers
AVCNF
JAZZ
Tags
AVCNF
JAZZ
Aras Azadian
From
Benzinga
Avicanna's CBD Derma-Cosmetics To Reach European Union Market Via Bio-Gate Partnership
April 05, 2022
Tickers
AVCNF
Tags
Benzinga
Small Business
Startups
From
Benzinga
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
February 14, 2022
Tickers
AVCNF
TBPMF
Tags
News
Benzinga
Penny Stocks
From
Benzinga
Avicanna Provides Q4-2021 Results And Fiscal 2022 Guidance
February 02, 2022
Tickers
AVCNF
Tags
Aras Azadian
AVCNF
Markets
From
Benzinga
Cannabis Movers & Shakers: Aurora Bolsters Management, Curaleaf Names New Pres, Verano & Avicanna's New Appointments
January 04, 2022
Tickers
ACB
AVCNF
AZN
CURLF
Tags
Small Cap
VRNOF
Joe Bayern
From
Benzinga
Avicanna Debuts CBD Derma-Cosmetics Pura H&W In US Via Deal With Red White & Bloom
December 22, 2021
Tickers
AVCNF
CBD
RWBYF
Tags
Aras Azadian
Retail Sales
AVCNF
From
Benzinga
Cannabis Movers & Shakers: Aurora Cannabis, Dama Financial, Neptune Wellness, Avicanna
November 15, 2021
Tickers
ACB
AVCNF
C
FDC
Tags
Entrepreneurship
Aras Azadian
AVCNF
From
Benzinga
Avicanna's CEO Touts Q3 As 'Most Successful Quarter To Date' As It Posts Record Results, Expands Into 12th International Market
November 15, 2021
Tickers
AVCNF
Tags
Market News
Cannabis
Markets
From
Benzinga
Cannabis Movers & Shakers: Synendos Therapeutics, Rapid Therapeutic Science Laboratories, Palo Santo, Avicanna
November 10, 2021
Tickers
AVCNF
RTSL
Tags
RTSL
General
Movers & Shakers
From
Benzinga
Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
September 24, 2021
Tickers
AVCNF
Tags
AVCNF
Aras Azadian
CBD Epilepsy
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.